Prognostic Impact of Elevated Pulmonary Vascular Resistance in Group 2 Pulmonary Hypertension: Insights From a Japanese Multicenter Registry.

Among patients with PH‐HFpEF, those associated with PVR >3 WU exhibited a numerically higher risk of adverse outcomes than those with a lower PVR, although the difference did not reach statistical significance (HR 1.70, 95% CI 0.78–3.71; log‐rank P =0.179) (Figure 3 ).

also in 111,027 other papers